← Eichor
Study identifier: NCT05711485 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Platelet-Directed Whole Blood Transfusion Strategy for Malaria

Condition: Severe Malaria · Thrombocytopenia  ·  Sponsor: Johns Hopkins Bloomberg School of Public Health

PhaseNA
Planned participants132
Who can joinAll sexes, 6 Months to 59 Months
Healthy volunteersNo

About this study

Open-label randomized controlled trial to test the effectiveness of whole blood transfusion for improving survival in children with severe malaria complicated by thrombocytopenia.

This description comes directly from the study's public registry record.

Talk to the study team

Matthew M Ippolito, MD PhD  ·  443-287-4809  ·  mippolito@jhu.edu

Always discuss trial participation with your own doctor first.

Locations (2)

Johns Hopkins Bloomberg School of Public HealthBaltimore, Maryland, United StatesNot Yet Recruiting
Tropical Diseases Research CentreNdola, Copperbelt, ZambiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05711485